ARMP - Armata Pharmaceuticals GAAP EPS of -$0.17 revenue of $0.98M August, 14 2023 09:41 AM Armata Pharmaceuticals Inc. 2023-08-14 09:41:38 ET Armata Pharmaceuticals press release ( NYSE: ARMP ): Q2 GAAP EPS of -$0.17. Revenue of $0.98M (-47.9% Y/Y). For further details see: Armata Pharmaceuticals GAAP EPS of -$0.17, revenue of $0.98M